The Effects of Extracellular Vesicles Derived from Krüppel-Like Factor 2 Overexpressing Endothelial Cells on the Regulation of Cardiac Inflammation in the Dilated Cardiomyopathy
Overview
Authors
Affiliations
Background: Dilated cardiomyopathy (DCM) is one of the common causes of heart failure. Myocardial injury triggers an inflammatory response and recruits immune cells into the heart. High expression of Krüppel-like factor 2 (KLF2) in endothelial cells (ECs) potentially exerts an anti-inflammatory effect. However, the role of extracellular vesicles (EVs) from KLF2-overexpressing ECs (KLF2-EVs) in DCM remains unclear.
Methods And Results: EVs were separated from the supernatant of KLF2-overexpressing ECs by gradient centrifugation. Mice were repeatedly administered low-dose doxorubicin (DOX) and then received KLF2-EVs through an intravenous injection. Treatment with KLF2-EVs prevented doxorubicin-induced left ventricular dysfunction and reduced the recruitment of Ly6 Mo/Mø in the myocardium. We used flow cytometry to detect Ly6 monocytes in bone marrow and spleen tissues and to elucidate the mechanisms underlying this beneficial effect. KLF2-EVs increased the retention of Ly6C monocytes in the bone marrow but not in the spleen tissue. KLF2-EVs also significantly downregulated C-C chemokine receptor 2 (CCR2) protein expression in cells from the bone marrow.
Conclusions: EVs derived from KLF2-overexpressing ECs reduced cardiac inflammation and ameliorated left ventricular dysfunction in DCM mice by targeting the CCR2 protein to inhibit Ly6C monocyte mobilization from the bone marrow.
Small Extracellular Vesicles from Breast Cancer Cells Induce Cardiotoxicity.
Osorio-Mendez J, Gomez-Grosso L, Montoya-Ortiz G, Novoa-Herran S, Dominguez-Romero Y Int J Mol Sci. 2025; 26(3).
PMID: 39940718 PMC: 11816698. DOI: 10.3390/ijms26030945.
Krüpple-like factors in cardiomyopathy: emerging player and therapeutic opportunities.
Gui L, Liu H, Jin L, Peng X Front Cardiovasc Med. 2024; 11:1342173.
PMID: 38516000 PMC: 10955087. DOI: 10.3389/fcvm.2024.1342173.
Unraveling the Signaling Dynamics of Small Extracellular Vesicles in Cardiac Diseases.
Cano-Carrillo S, Castillo-Casas J, Franco D, Lozano-Velasco E Cells. 2024; 13(3.
PMID: 38334657 PMC: 10854837. DOI: 10.3390/cells13030265.
Extracellular vesicles in cardiomyopathies: A narrative review.
Rizzuto A, Faggiano A, Macchi C, Carugo S, Perrino C, Ruscica M Heliyon. 2024; 10(1):e23765.
PMID: 38192847 PMC: 10772622. DOI: 10.1016/j.heliyon.2023.e23765.
Extracellular Vesicles: A New Frontier for Cardiac Repair.
You B, Yang Y, Zhou Z, Yan Y, Zhang L, Jin J Pharmaceutics. 2022; 14(9).
PMID: 36145595 PMC: 9503573. DOI: 10.3390/pharmaceutics14091848.